CERS240517C1500
- 0.55
- 0.000.00%
Cerus Newsroom
Cerus(CERS.US) Director Buys US$4,974.75 in Common Stock
$Cerus(CERS.US)$ Director Shan Hua purchased 2,500 shares of common stock on May 13, 2024 at an average price of $1.9899 for a total value of $4,974.75.Source: Announcement What is statement of change
Zomedica And 3 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed lower by over 80 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inte
Cerus(CERS.US) Director Buys US$3,578.2 in Common Stock
$Cerus(CERS.US)$ Director NACHTSHEIM JAMI K purchased 2,000 shares of common stock on May 10, 2024 at an average price of $1.7891 for a total value of $3,578.2.Source: Announcement What is statement o
Cerus(CERS.US) Director Buys US$37,800 in Common Stock
$Cerus(CERS.US)$ Director Witney Frank purchased 20,000 shares of common stock on May 9, 2024 at an average price of $1.89 for a total value of $37,800.Source: Announcement What is statement of change
ESS Tech And 2 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed higher by over 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders
Cerus(CERS.US) Director Buys US$4,688.75 in Common Stock
$Cerus(CERS.US)$ Director Swisher Daniel N JR purchased 2,500 shares of common stock on May 9, 2024 at an average price of $1.8755 for a total value of $4,688.75.Source: Announcement What is statement
Cerus's Strong Q1 Growth and Promising INTERCEPT Technology Drive Buy Rating
Cerus First Quarter 2024 Earnings: EPS Misses Expectations
Cerus Is Maintained at Overweight by Cantor Fitzgerald
Cerus Is Maintained at Overweight by Cantor Fitzgerald
Cerus Price Target Raised to $4.00/Share From $3.00 by Cantor Fitzgerald
Cerus Price Target Raised to $4.00/Share From $3.00 by Cantor Fitzgerald
Express News | Cantor Fitzgerald Maintains Overweight on Cerus, Raises Price Target to $4
Cerus Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 130.55% Cantor Fitzgerald $3 → $4 Maintains Overweight 04/12/2024 188.18% Craig-Hallum → $5 Ini
Analysts' Opinions Are Mixed on These Healthcare Stocks: Joint (JYNT) and Cerus (CERS)
Earnings Call Summary | Cerus(CERS.US) Q1 2024 Earnings Conference
The following is a summary of the Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript:Financial Performance:Cerus reported Q1 2024 product revenue of $38.4 million, a 24% YoY growth, largely fro
Cerus Corp (CERS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
Cerus On Track to Post Double-Digit Pdt Rev Growth This Yr >CERS
Cerus On Track to Post Double-Digit Pdt Rev Growth This Yr >CERS
Cerus Committed to Adjusted EBITDA Breakeven for FY24
Cerus Committed to Adjusted EBITDA Breakeven for FY24
Cerus Expects to Report a GAAP Loss Attributable to Co for FY24
Cerus Expects to Report a GAAP Loss Attributable to Co for FY24
Earnings Flash (CERS) CERUS CORPORATION Posts Q1 Revenue $43.4M, Vs. Street Est of $38.4M
04:01 PM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (CERS) CERUS CORPORATION Posts Q1 Revenue $43.4M, vs. Street Est of $38.4M
Cerus Backs FY Product Rev Guidance Range of $172 M to $175 M >CERS
Cerus Backs FY Product Rev Guidance Range of $172 M to $175 M >CERS